Middle East Pharmaceutical Industries Co. announces its Interim Financial results for the Period Ending on 2025-03-31 ( Three Months )
| Element List | Current Quarter | Similar quarter for previous year | %Change | Previous Quarter | % Change |
|---|---|---|---|---|---|
| Sales/Revenue | 97.36 | 75.82 | 28.409 | 135.99 | -28.406 |
| Gross Profit (Loss) | 60.27 | 45.3 | 33.046 | 89.15 | -32.394 |
| Operational Profit (Loss) | 22.3 | 12.33 | 80.859 | 47.24 | -52.794 |
| Net profit (Loss) | 19.4 | 9.37 | 107.043 | 44.81 | -56.706 |
| Total Comprehensive Income | 19.4 | 9.1 | 113.186 | 42.02 | -53.831 |
| All figures are in (Millions) Saudi Arabia, Riyals | |||||
| Element List | Current Period | Similar period for previous year | %Change |
|---|---|---|---|
| Total Shareholders Equity (after Deducting Minority Equity) | 387.61 | 315.5 | 22.855 |
| Profit (Loss) per Share | 0.97 | 0.47 | |
| All figures are in (Millions) Saudi Arabia, Riyals | |||
| Element List | Amount | Percentage of the capital (%) | |
|---|---|---|---|
| Profit (Losses) Resulting From The Change In Investment Propertie’s Fair Value | - | - | |
| All figures are in (Millions) Saudi Arabia, Riyals | |||
| Element List | Explanation |
|---|---|
| The reason of the increase (decrease) in the sales/ revenues during the current quarter compared to the same quarter of the last year is | The key drivers of the business reflect a significant increase in the figures on a year-on-year basis, with revenue increasing 28% compared to the same quarter of 2024, hitting 97.4m. This increase was driven by robust sales performance in both the private and public sectors, which contributed 12m and 14m, respectively.
This was also complimented by a large increase in the number of new customer accounts opened post Q1 2024, along with the launch of several products in that same time period, but partially offset by the Company’s sales phasing strategy, which has been carefully aligned with the movements of the international markets in which it operates. |
| The reason of the increase (decrease) in the net profit during the current quarter compared to the same quarter of the last year is | The Company posted a net profit of SAR 19.4 million, growing 107% year-on-year from SAR 9.37 million in the same quarter of last year. This is mainly attributed to:
- A visible increase in the gross profit of 33% due to remarkable sales growth and the improved gross margin.
- It is partially offset by the increase in selling & distribution expenses; and in general & administrative expenses, reflecting the company’s ongoing commitment to investment in growth. |
| The reason of the increase (decrease) in the sales/ revenues during the current quarter compared to the previous one is | The decrease of 28% in revenue for the first quarter of 2025 (SAR 97.36 million), as compared to the fourth quarter of 2024 (SAR 136 million), is mainly attributed to the business dynamics and internal decisions based on the seasonality of our products and phasing of the sales during the first quarter of the year . |
| The reason of the increase (decrease) in the net profit (loss) during the current quarter compared to the previous one is | The decrease in the net profit for the first quarter of 2025 (SAR 19.4 million), as compared to the fourth quarter of 2024 (SAR 44.81 million) is mainly attributed to the lower sales during the quarter, as explained above, which has resulted in a lower gross profit. |
| Statement of the type of external auditor's report | Unmodified conclusion |
| Comment mentioned in the external auditor’s report, mentioned in any of the following paragraphs (other matter, conservation, notice, disclaimer of opinion, or adverse opinion) | No |
| Reclassification of Comparison Items | Certain comparative figures have been reclassified to conform with the classification used for the quarter ended 31 March 2025. |
| Additional Information | No |
| Attached Documents |  |
Comments